APA (7th ed.) Citation

MJ, v. d. B., PJ, F., D, B., JC, T., M, T., BM, E., . . . PY, W. (2024). The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? Neuro-oncology, 26(10), 1805. https://doi.org/10.1093/neuonc/noae107

Chicago Style (17th ed.) Citation

MJ, van den Bent, et al. "The Biological Significance of Tumor Grade, Age, Enhancement, and Extent of Resection in IDH-mutant Gliomas: How Should They Inform Treatment Decisions in the Era of IDH Inhibitors?" Neuro-oncology 26, no. 10 (2024): 1805. https://doi.org/10.1093/neuonc/noae107.

MLA (9th ed.) Citation

MJ, van den Bent, et al. "The Biological Significance of Tumor Grade, Age, Enhancement, and Extent of Resection in IDH-mutant Gliomas: How Should They Inform Treatment Decisions in the Era of IDH Inhibitors?" Neuro-oncology, vol. 26, no. 10, 2024, p. 1805, https://doi.org/10.1093/neuonc/noae107.